Zhejiang Huahai Pharmaceutical Co., Ltd.
600521.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.13B
Close$
Share Statistics
| Market cap | $26.13 Billion |
|---|---|
| Enterprise Value | $33.09 Billion |
| Dividend Yield | $0.10 (0.57%) |
| Earnings per Share | $0.18 |
| Beta | 0.13 |
| Outstanding Shares | 1,490,228,596 |
Return
| Return on Equity | 6.43% |
|---|---|
| Return on Assets | 2.86% |
| Return on Invested Capital | 5.15% |
Valuation & Multiples
| P/E Ratio | 41.5 |
|---|---|
| PEG | 18.27 |
| Price to Sales | 2.91 |
| Price to Book Ratio | 2.49 |
| Enterprise Value to Revenue | 3.68 |
| Enterprise Value to EBIT | 47.86 |
| Enterprise Value to Net Income | 52 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.9 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$2.37 B
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$2.11 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Huahai Pharmaceutical Co., Ltd.
8,797 employees
CEO: Bao Hua Chen Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infection...